TARBP2 and metastatic malignant neoplasm in the lymph nodes: Patients with TARBP2 gene mutation were more likely to have lymph node metastasis (OR = 2.49, 95% CI = 1.14–5.46, p = 0.022) and advanced disease stage (OR = 2.20, 95% CI = 1.08–4.46, p = 0.029).